A Long-term Follow-up Study of Acellular Dermal Matrix With Thin Autograft in Burns Patients

2011 ◽  
Vol 67 (4) ◽  
pp. 346-351 ◽  
Author(s):  
Yunchuan Pan ◽  
Zunhong Liang ◽  
Su Yuan ◽  
Jiaqin Xu ◽  
Jun Wang ◽  
...  
Keyword(s):  
Acellular Dermal Matrix ◽  
Dermal Matrix ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
Acellular Dermal

Abdominal wall repair using human acellular dermal matrix: a follow-up study

2009 ◽  
Vol 198 (5) ◽  
pp. 650-657 ◽  
Author(s):  
Edward I. Lee ◽  
Chuma J. Chike-Obi ◽  
Patricio Gonzalez ◽  
Ramon Garza ◽  
Mimi Leong ◽  
...  
Keyword(s):  
Abdominal Wall ◽  
Acellular Dermal Matrix ◽  
Dermal Matrix ◽  
Abdominal Wall Repair ◽  
Follow Up Study ◽  
Acellular Dermal ◽  
Human Acellular Dermal Matrix

scholarly journals Evaluation of Complication Rates after Breast Surgery Using Acellular Dermal Matrix: Median Follow-Up of Three Years

2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Felix J. Paprottka ◽  
Nicco Krezdorn ◽  
Heiko Sorg ◽  
Sören Könneker ◽  
Stiliano Bontikous ◽  
...  
Keyword(s):  
Capsular Contracture ◽  
Composite Endpoint ◽  
Acellular Dermal Matrix ◽  
Complication Rates ◽  
Dermal Matrix ◽  
Long Term Follow Up ◽  
Retrospective Data Collection ◽  
Dermal Matrices ◽  
Acellular Dermal

Introduction. Acellular dermal matrices (ADMs) are now commonly used for breast reconstruction surgery. There are various products available: ADMs derived from human (HADM), porcine (PADM), or bovine (BADM) sources. Detailed long-term follow-up studies are necessary to detect differences in complication rates between these products. Material and Methods. From 2010 to 2015, forty-one patients underwent 52 ADM-breast reconstructions in our clinic, including oncologic breast reconstructions and breast augmentation revisions (n=52). 15x HADMs (Epiflex®/DIZG), 21x PADMs (Strattice®/LifeCell), and 16x BADMs (Tutomesh®/RTI Surgical) were implanted. Retrospective data collection with median follow-up of 36 months (range: 12–54 months) was performed. Results. Overall complication rate was 17% after ADM implantation (HADM: 7%; PADM: 14%; BADM: 31%). In a composite endpoint of complications and Red Breast Syndrome, a lower event probability was observed between BADMs, PADMs, and HADMs (44%, 19%, and 7%, resp.; p=0.01 for the trend). Furthermore, capsular contracture occurred in 6%, more frequently as compared to the current literature. Conclusions. When ADM-based reconstruction is indicated, the authors suggest primarily the use of HADMs and secondary the use of PADMs. It is shown that BADMs have the highest complication probability within our patient cohort; nevertheless, BADMs convey physical advantages in terms of flexibility and better aesthetic outcomes. The indication for the use of ADMs should be filled for each case individually.

scholarly journals Subpectoral Implant Repositioning With Partial Capsule Preservation: Treating the Long-Term Complications of Subglandular Breast Augmentation

2021 ◽  
Author(s):  
Adam T Hauch ◽  
Cameron S Francis ◽  
Jourdain D Artz ◽  
Paul E Chasan
Keyword(s):  
Breast Augmentation ◽  
Capsular Contracture ◽  
Pectoralis Major Muscle ◽  
Acellular Dermal Matrix ◽  
Dermal Matrix ◽  
Average Patient ◽  
Technical Details ◽  
Acellular Dermal

Abstract Background Patients with long-term complications associated with subglandular breast augmentation are being seen in increasing numbers in the Southern California community. Late deformities include a characteristic “slide-down” deformity, as well as capsular contracture, implant wrinkling, and areolar enlargement. Repositioning the implant to a subpectoral pocket is a recognized revisionary technique to treat this problem; however, technical details of how this is accomplished are lacking in the literature. Objectives To review our technique for treating long-term complications associated with subglandular implants using subpectoral repositioning with partial capsule preservation and mastopexy, without the need for an acellular dermal matrix (ADMs) or mesh. Methods Retrospective review of all patients undergoing subpectoral repositioning over the course of six years was performed. Patient data and long-term outcomes were assessed. A technique is presented utilizing a partial capsulectomy that preserves a portion of the capsule as an ADM/mesh equivalent, ensuring adequate implant coverage and preventing window-shading of the pectoralis major muscle. Results Twenty-four patients with subglandular implants and slide-down deformity as well as other associated complications including capsular contracture, implant wrinkling, and enlarged areolas underwent revision surgery with a subpectoral site change. Often, patients presented many years after their initial augmentation (mean 18 years, range 4-38 years). Average patient follow-up was 3.1 years (range 1.0 – 6.8 years). Two patients required minor revisions with local anesthetic while another two revisions required general anesthesia. Conclusions Long-term deformities associated with subglandular breast augmentation can reliably be corrected by subpectoral repositioning, mastopexy, and utilization of residual breast capsule in place of an ADM or mesh.

Sign in / Sign up

Export Citation Format

Share Document